The clock is ticking for Iterum after FDA hands down CRL for Pfizer castoff antibiotic

The FDA has sent the tiny biotech a complete response letter for the antibiotic sulopenem, shutting down hopes at getting the oral medication across the finish line, the drugmaker revealed Monday.